Philips Announces Q1 Results Aligned with 2024 Plan, Settles Respironi
- ICU
- 29/04/2024
Philips Announces Q1 Results Aligned with 2024 Plan, Settles Respironics Litigation for $1.1 Billion
READ MOREPhilips Announces Q1 Results Aligned with 2024 Plan, Settles Respironics Litigation for $1.1 Billion
READ MOREMasimo Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
READ MOREShaping Kidney Care: Fresenius Medical Care 2023 Annual & Sustainability Report
READ MOREFresenius Medical Care: “Augmented Reality” for training on Kidney Replacement Therapy device
READ MOREAcadia Hospital welcomes Kristen Sparks, MD to Consult Services
READ MOREMasimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
READ MOREFresenius Medical Care Portfolio Optimization Announcing Sale of Dialysis Clinics
READ MORERare Diseases: No Innovative Therapies Without Research
READ MOREMasimo SET® Pulse Oximetry Accurate Across Black & White Subjects, Even in Low Perfusion
READ MOREFresenius Medical Care Introduces Leading Dialysis Therapy for U.S. Kidney Patients
READ MORE